ANAB
Price
$30.94
Change
-$0.40 (-1.28%)
Updated
Oct 3 closing price
Capitalization
865.48M
36 days until earnings call
ZURA
Price
$3.93
Change
-$0.17 (-4.15%)
Updated
Oct 3 closing price
Capitalization
255.52M
Interact to see
Advertisement

ANAB vs ZURA

Header iconANAB vs ZURA Comparison
Open Charts ANAB vs ZURABanner chart's image
AnaptysBio
Price$30.94
Change-$0.40 (-1.28%)
Volume$353.61K
Capitalization865.48M
Zura Bio
Price$3.93
Change-$0.17 (-4.15%)
Volume$973.2K
Capitalization255.52M
ANAB vs ZURA Comparison Chart in %
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. ZURA commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Buy and ZURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ANAB: $30.94 vs. ZURA: $3.93)
Brand notoriety: ANAB and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 59% vs. ZURA: 53%
Market capitalization -- ANAB: $865.48M vs. ZURA: $255.52M
ANAB [@Biotechnology] is valued at $865.48M. ZURA’s [@Biotechnology] market capitalization is $255.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 5 TA indicator(s) are bullish while ZURA’s TA Score has 5 bullish TA indicator(s).

  • ANAB’s TA Score: 5 bullish, 4 bearish.
  • ZURA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZURA is a better buy in the short-term than ANAB.

Price Growth

ANAB (@Biotechnology) experienced а +31.21% price change this week, while ZURA (@Biotechnology) price change was +63.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANAB($865M) has a higher market cap than ZURA($256M). ANAB YTD gains are higher at: 133.686 vs. ZURA (57.200). ANAB has higher annual earnings (EBITDA): -59.63M vs. ZURA (-72.34M). ANAB has more cash in the bank: 266M vs. ZURA (154M). ANAB has higher revenues than ZURA: ANAB (123M) vs ZURA (0).
ANABZURAANAB / ZURA
Capitalization865M256M338%
EBITDA-59.63M-72.34M82%
Gain YTD133.68657.200234%
P/E RatioN/A7.96-
Revenue123M0-
Total Cash266M154M173%
Total Debt15.1MN/A-
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABZURA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
42%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
55%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
54%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
48%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 21 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
44%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMRBX5.000.03
+0.60%
American Growth One B
CBBZX6.870.02
+0.29%
AB Relative Value Z
TEOIX10.760.03
+0.28%
Transamerica Emerging Markets Eq I
AMONX25.13-0.08
-0.32%
AQR Large Cap Momentum Style N
BGSAX75.61-0.31
-0.41%
BlackRock Technology Opportunities Inv A

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with QTTB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
-1.28%
QTTB - ANAB
39%
Loosely correlated
N/A
CLRB - ANAB
38%
Loosely correlated
-0.34%
AMRN - ANAB
38%
Loosely correlated
+12.54%
ADCT - ANAB
37%
Loosely correlated
+2.51%
ZURA - ANAB
36%
Loosely correlated
-4.15%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-4.15%
SYRE - ZURA
44%
Loosely correlated
-0.56%
FATE - ZURA
42%
Loosely correlated
N/A
CGON - ZURA
42%
Loosely correlated
-0.09%
IPSC - ZURA
39%
Loosely correlated
+3.16%
BDTX - ZURA
38%
Loosely correlated
+4.29%
More